BNP Paribas Financial Markets’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.29M | Buy |
|
|||||
|
2023
Q3 | $2.39M | Buy |
|
|||||
|
2023
Q2 | $1.38M | Sell |
|
|||||
|
2023
Q1 | $2.44M | Sell |
|
|||||
|
2022
Q4 | $15.9M | Buy |
|
|||||
|
2022
Q3 | $4.37M | Buy |
|
|||||
|
2022
Q2 | $320K | Sell |
|
|||||
|
2022
Q1 | $2.23M | Sell |
|
|||||
|
2021
Q4 | $6.05M | Buy |
|
|||||
|
2021
Q3 | $203K | Buy |
|
|||||
|
2021
Q2 | $105K | Sell |
|
|||||
|
2021
Q1 | $950K | Sell |
|
|||||
|
2020
Q4 | $1.62M | Sell |
|
|||||
|
2020
Q3 | $1.46M | Buy |
|
|||||
|
2020
Q2 | $434K | Sell |
|
|||||
|
2020
Q1 | $1.24M | Buy |
|
|||||
|
2019
Q4 | $523K | Sell |
|
|||||
|
2019
Q3 | $384K | Buy |
|
|||||
|
2019
Q2 | $325K | Sell |
|
|||||
|
2019
Q1 | $354K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $27.9K | Hold |
|
|||||
|
2018
Q2 | $29.2K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $23 | Hold |
|
|||||
|
2017
Q2 | $7 | Sell |
|
|||||
|
2017
Q1 | $2.43K | Sell |
|
|||||
|
2016
Q4 | $3.6K | Sell |
|
|||||
|
2016
Q3 | $5.96K | Buy |
|
|||||
|
2016
Q2 | $2.95K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $71.7K | Buy |
|
|||||
|
2015
Q3 | $71.4K | Buy |
|
|||||
|
2015
Q2 | $26.1K | Buy |
|
|||||
|
2015
Q1 | $5.8K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $2.1K | Buy |
|